Cargando…
Pharmacokinetics of Anti‐VEGF Agent Aflibercept in Cancer Predicted by Data‐Driven, Molecular‐Detailed Model
Mathematical models can support the drug development process by predicting the pharmacokinetic (PK) properties of the drug and optimal dosing regimens. We have developed a pharmacokinetic model that includes a biochemical molecular interaction network linked to a whole‐body compartment model. We app...
Autores principales: | Finley, SD, Angelikopoulos, P, Koumoutsakos, P, Popel, AS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716581/ https://www.ncbi.nlm.nih.gov/pubmed/26783500 http://dx.doi.org/10.1002/psp4.12040 |
Ejemplares similares
-
Data driven inference for the repulsive exponent of the Lennard-Jones potential in molecular dynamics simulations
por: Kulakova, Lina, et al.
Publicado: (2017) -
Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies
por: Finley, Stacey D, et al.
Publicado: (2011) -
Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug
por: Stewart, Michael W
Publicado: (2012) -
Compartment Model Predicts VEGF Secretion and Investigates the Effects of VEGF Trap in Tumor-Bearing Mice
por: Finley, Stacey D., et al.
Publicado: (2013) -
Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose
por: Veritti, Daniele, et al.
Publicado: (2023)